Induction of Caspase Activation and Cleavage of the Viral Nucleocapsid Protein in Different Cell Types during Crimean-Congo Hemorrhagic Fever Virus Infection

Regulation of apoptosis during infection has been observed for several viral pathogens. Programmed cell death and regulation of apoptosis in response to a viral infection are important factors for host or virus survival. It is not known whether Crimean-Congo hemorrhagic fever virus (CCHFV) infection...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of biological chemistry Vol. 286; no. 5; pp. 3227 - 3234
Main Authors Karlberg, Helen, Tan, Yee-Joo, Mirazimi, Ali
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 04.02.2011
American Society for Biochemistry and Molecular Biology
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Regulation of apoptosis during infection has been observed for several viral pathogens. Programmed cell death and regulation of apoptosis in response to a viral infection are important factors for host or virus survival. It is not known whether Crimean-Congo hemorrhagic fever virus (CCHFV) infection regulates the apoptosis process in vitro. This study for the first time suggests that CCHFV induces apoptosis, which may be dependent on caspase-3 activation. This study also shows that the coding sequence of the S segment of CCHFV contains a proteolytic cleavage site, DEVD, which is conserved in all CCHFV strains. By using different recombinant expression systems and site-directed mutagenesis, we demonstrated that this motif is subject to caspase cleavage. We also demonstrate that CCHFV nucleocapsid protein (NP) is cleaved into a 30-kDa fragment at the same time as caspase activity is induced during infection. Using caspase inhibitors and cells lacking caspase-3, we clearly demonstrate that the cleavage of NP is caspase-3-dependent. We also show that the inhibition of apoptosis induced progeny viral titers of ∼80–90%. Thus, caspase-3-dependent cleavage of NP may represent a host defense mechanism against lytic CCHFV infection. Taken together, these data suggest that the most abundant protein of CCHFV, which has several essential functions such as protection of viral RNA and participation in various processes in the replication cycle, can be subjected to cleavage by host cell caspases.
AbstractList Regulation of apoptosis during infection has been observed for several viral pathogens. Programmed cell death and regulation of apoptosis in response to a viral infection are important factors for host or virus survival. It is not known whether Crimean-Congo hemorrhagic fever virus (CCHFV) infection regulates the apoptosis process in vitro. This study for the first time suggests that CCHFV induces apoptosis, which may be dependent on caspase-3 activation. This study also shows that the coding sequence of the S segment of CCHFV contains a proteolytic cleavage site, DEVD, which is conserved in all CCHFV strains. By using different recombinant expression systems and site-directed mutagenesis, we demonstrated that this motif is subject to caspase cleavage. We also demonstrate that CCHFV nucleocapsid protein (NP) is cleaved into a 30-kDa fragment at the same time as caspase activity is induced during infection. Using caspase inhibitors and cells lacking caspase-3, we clearly demonstrate that the cleavage of NP is caspase-3-dependent. We also show that the inhibition of apoptosis induced progeny viral titers of ~80-90%. Thus, caspase-3-dependent cleavage of NP may represent a host defense mechanism against lytic CCHFV infection. Taken together, these data suggest that the most abundant protein of CCHFV, which has several essential functions such as protection of viral RNA and participation in various processes in the replication cycle, can be subjected to cleavage by host cell caspases.
Regulation of apoptosis during infection has been observed for several viral pathogens. Programmed cell death and regulation of apoptosis in response to a viral infection are important factors for host or virus survival. It is not known whether Crimean-Congo hemorrhagic fever virus (CCHFV) infection regulates the apoptosis process in vitro. This study for the first time suggests that CCHFV induces apoptosis, which may be dependent on caspase-3 activation. This study also shows that the coding sequence of the S segment of CCHFV contains a proteolytic cleavage site, DEVD, which is conserved in all CCHFV strains. By using different recombinant expression systems and site-directed mutagenesis, we demonstrated that this motif is subject to caspase cleavage. We also demonstrate that CCHFV nucleocapsid protein (NP) is cleaved into a 30-kDa fragment at the same time as caspase activity is induced during infection. Using caspase inhibitors and cells lacking caspase-3, we clearly demonstrate that the cleavage of NP is caspase-3-dependent. We also show that the inhibition of apoptosis induced progeny viral titers of similar to 80-90%. Thus, caspase-3-dependent cleavage of NP may represent a host defense mechanism against lytic CCHFV infection. Taken together, these data suggest that the most abundant protein of CCHFV, which has several essential functions such as protection of viral RNA and participation in various processes in the replication cycle, can be subjected to cleavage by host cell caspases.
Regulation of apoptosis during infection has been observed for several viral pathogens. Programmed cell death and regulation of apoptosis in response to a viral infection are important factors for host or virus survival. It is not known whether Crimean-Congo hemorrhagic fever virus (CCHFV) infection regulates the apoptosis process in vitro . This study for the first time suggests that CCHFV induces apoptosis, which may be dependent on caspase-3 activation. This study also shows that the coding sequence of the S segment of CCHFV contains a proteolytic cleavage site, DEVD, which is conserved in all CCHFV strains. By using different recombinant expression systems and site-directed mutagenesis, we demonstrated that this motif is subject to caspase cleavage. We also demonstrate that CCHFV nucleocapsid protein (NP) is cleaved into a 30-kDa fragment at the same time as caspase activity is induced during infection. Using caspase inhibitors and cells lacking caspase-3, we clearly demonstrate that the cleavage of NP is caspase-3-dependent. We also show that the inhibition of apoptosis induced progeny viral titers of ∼80–90%. Thus, caspase-3-dependent cleavage of NP may represent a host defense mechanism against lytic CCHFV infection. Taken together, these data suggest that the most abundant protein of CCHFV, which has several essential functions such as protection of viral RNA and participation in various processes in the replication cycle, can be subjected to cleavage by host cell caspases.
Regulation of apoptosis during infection has been observed for several viral pathogens. Programmed cell death and regulation of apoptosis in response to a viral infection are important factors for host or virus survival. It is not known whether Crimean-Congo hemorrhagic fever virus (CCHFV) infection regulates the apoptosis process in vitro. This study for the first time suggests that CCHFV induces apoptosis, which may be dependent on caspase-3 activation. This study also shows that the coding sequence of the S segment of CCHFV contains a proteolytic cleavage site, DEVD, which is conserved in all CCHFV strains. By using different recombinant expression systems and site-directed mutagenesis, we demonstrated that this motif is subject to caspase cleavage. We also demonstrate that CCHFV nucleocapsid protein (NP) is cleaved into a 30-kDa fragment at the same time as caspase activity is induced during infection. Using caspase inhibitors and cells lacking caspase-3, we clearly demonstrate that the cleavage of NP is caspase-3-dependent. We also show that the inhibition of apoptosis induced progeny viral titers of ∼80-90%. Thus, caspase-3-dependent cleavage of NP may represent a host defense mechanism against lytic CCHFV infection. Taken together, these data suggest that the most abundant protein of CCHFV, which has several essential functions such as protection of viral RNA and participation in various processes in the replication cycle, can be subjected to cleavage by host cell caspases.
Regulation of apoptosis during infection has been observed for several viral pathogens. Programmed cell death and regulation of apoptosis in response to a viral infection are important factors for host or virus survival. It is not known whether Crimean-Congo hemorrhagic fever virus (CCHFV) infection regulates the apoptosis process in vitro. This study for the first time suggests that CCHFV induces apoptosis, which may be dependent on caspase-3 activation. This study also shows that the coding sequence of the S segment of CCHFV contains a proteolytic cleavage site, DEVD, which is conserved in all CCHFV strains. By using different recombinant expression systems and site-directed mutagenesis, we demonstrated that this motif is subject to caspase cleavage. We also demonstrate that CCHFV nucleocapsid protein (NP) is cleaved into a 30-kDa fragment at the same time as caspase activity is induced during infection. Using caspase inhibitors and cells lacking caspase-3, we clearly demonstrate that the cleavage of NP is caspase-3-dependent. We also show that the inhibition of apoptosis induced progeny viral titers of ∼80-90%. Thus, caspase-3-dependent cleavage of NP may represent a host defense mechanism against lytic CCHFV infection. Taken together, these data suggest that the most abundant protein of CCHFV, which has several essential functions such as protection of viral RNA and participation in various processes in the replication cycle, can be subjected to cleavage by host cell caspases.Regulation of apoptosis during infection has been observed for several viral pathogens. Programmed cell death and regulation of apoptosis in response to a viral infection are important factors for host or virus survival. It is not known whether Crimean-Congo hemorrhagic fever virus (CCHFV) infection regulates the apoptosis process in vitro. This study for the first time suggests that CCHFV induces apoptosis, which may be dependent on caspase-3 activation. This study also shows that the coding sequence of the S segment of CCHFV contains a proteolytic cleavage site, DEVD, which is conserved in all CCHFV strains. By using different recombinant expression systems and site-directed mutagenesis, we demonstrated that this motif is subject to caspase cleavage. We also demonstrate that CCHFV nucleocapsid protein (NP) is cleaved into a 30-kDa fragment at the same time as caspase activity is induced during infection. Using caspase inhibitors and cells lacking caspase-3, we clearly demonstrate that the cleavage of NP is caspase-3-dependent. We also show that the inhibition of apoptosis induced progeny viral titers of ∼80-90%. Thus, caspase-3-dependent cleavage of NP may represent a host defense mechanism against lytic CCHFV infection. Taken together, these data suggest that the most abundant protein of CCHFV, which has several essential functions such as protection of viral RNA and participation in various processes in the replication cycle, can be subjected to cleavage by host cell caspases.
Author Karlberg, Helen
Mirazimi, Ali
Tan, Yee-Joo
Author_xml – sequence: 1
  givenname: Helen
  surname: Karlberg
  fullname: Karlberg, Helen
  organization: From the Swedish Institute for Infectious Disease control, SE-171 82 Solna, Sweden
– sequence: 2
  givenname: Yee-Joo
  surname: Tan
  fullname: Tan, Yee-Joo
  organization: the Department of Microbiology, Yong Loo Lin School of Medicine, National University Health System, National University of Singapore, Singapore 117597, Singapore
– sequence: 3
  givenname: Ali
  surname: Mirazimi
  fullname: Mirazimi, Ali
  email: Ali.Mirazimi@smi.se
  organization: From the Swedish Institute for Infectious Disease control, SE-171 82 Solna, Sweden
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21123175$$D View this record in MEDLINE/PubMed
BookMark eNqFUl1vFCEUJaaN3VaffVPefJoWhplZeDFpRttuUj8SW-MbYeEySzMLK8xs0h_jf5XZbY2aNAIJAc45nJtzj9GBDx4QekXJKSXz6uxuqU8_0ulUCdaIZ2hGCWcFq-n3AzQjpKSFKGt-hI5TuiN5VII-R0clpSWj83qGfi68GfXggsfB4laljUqAz_PNVu1ulTe47UFtVQcTZFgB_uai6vGnUfcQtNokZ_CXGAZwHuf13lkLEfyAW-h7fHO_gYTNGJ3vcBvdGpQv2uC7gK9gHWJcqc5pfAFbiJPymPDCW9h5eoEOreoTvHzYT9DtxYeb9qq4_ny5aM-vC92QcihA8Kq0gjFFFOOqbOZMGcNNQ0AQ3tSMM04NYZbrqhGWWwAoRUOqqmqaZW3ZCXq3192MyzUYnc3nCuUmu1XxXgbl5N8v3q1kF7aSkTzLeRZ4-yAQw48R0iDXLulcvvIQxiQFmb7KsfwXySvecE7ZhHz9p6nfbh7Dy4B6D9AxpBTBSu2GXWrZo-slJXJqEpmbRE5NIvdNknln__AepZ9mvNkzrApSddElefu1JJQRKlhdU5IRYo-AHNPWQZRJO_AajIs5S2mCe1L9F5pf3Vw
CitedBy_id crossref_primary_10_1097_INF_0000000000000530
crossref_primary_10_1073_pnas_1200808109
crossref_primary_10_1371_journal_pone_0029712
crossref_primary_10_1016_j_coviro_2022_101278
crossref_primary_10_1128_JVI_00616_19
crossref_primary_10_1080_20477724_2021_1944539
crossref_primary_10_1099_jgv_0_000403
crossref_primary_10_1016_j_onehlt_2023_100529
crossref_primary_10_1099_jgv_0_000011
crossref_primary_10_1007_s00705_013_1940_z
crossref_primary_10_1080_21645515_2015_1078045
crossref_primary_10_1038_s41541_024_00931_y
crossref_primary_10_1038_s41579_023_00871_9
crossref_primary_10_1016_j_jsb_2016_09_013
crossref_primary_10_1074_jbc_M115_667436
crossref_primary_10_1128_JVI_01929_12
crossref_primary_10_1016_j_virs_2023_08_006
crossref_primary_10_1016_j_antiviral_2022_105244
crossref_primary_10_3201_eid2502_171999
crossref_primary_10_1007_s12250_018_0020_7
crossref_primary_10_1128_JVI_01680_15
crossref_primary_10_3390_v8040106
crossref_primary_10_12688_f1000research_16189_1
crossref_primary_10_1016_j_ttbdis_2020_101448
crossref_primary_10_1128_JVI_01864_13
crossref_primary_10_1371_journal_pntd_0009973
crossref_primary_10_1038_s41426_018_0192_0
crossref_primary_10_1128_JVI_01555_12
crossref_primary_10_1038_cddis_2012_18
crossref_primary_10_1089_vbz_2011_0766
crossref_primary_10_3390_v8060164
crossref_primary_10_1007_s00705_019_04236_7
crossref_primary_10_28982_josam_567579
crossref_primary_10_5812_jjm_59412
crossref_primary_10_7554_eLife_63906
crossref_primary_10_1038_cdd_2017_59
crossref_primary_10_1128_JVI_01627_12
crossref_primary_10_1128_jvi_01975_23
crossref_primary_10_1016_j_micinf_2017_10_002
crossref_primary_10_1016_j_antiviral_2015_05_005
crossref_primary_10_1002_jmv_24446
crossref_primary_10_1371_journal_pone_0108419
crossref_primary_10_1016_j_jcv_2014_08_029
crossref_primary_10_1371_journal_pone_0204264
crossref_primary_10_1186_s12985_023_02089_w
crossref_primary_10_1371_journal_ppat_1004879
crossref_primary_10_1128_JVI_01638_21
crossref_primary_10_1002_jmv_25467
crossref_primary_10_1016_j_antiviral_2013_07_006
crossref_primary_10_1080_01919512_2020_1822149
crossref_primary_10_1177_0300985815570068
crossref_primary_10_3390_v17020178
crossref_primary_10_1128_JVI_00081_19
Cites_doi 10.1016/S0163-7258(01)00159-0
10.1007/BF02255946
10.1074/jbc.M109.068221
10.1016/j.virol.2010.02.018
10.1055/s-0037-1613397
10.1038/nbt1291-1356
10.1007/s10549-008-0217-9
10.1586/14787210.4.6.917
10.1128/JVI.02310-09
10.1006/viro.1994.1309
10.1128/MMBR.00027-06
10.1002/jmv.20347
10.1002/jmv.10560
10.1002/jmv.21222
10.1016/S1473-3099(06)70435-2
10.1126/science.281.5381.1312
10.1099/0022-1317-71-3-501
10.1016/S0168-1702(02)00049-7
10.1006/viro.1999.9896
10.1128/JVI.73.12.10158-10163.1999
10.1128/JVI.77.14.7999-8008.2003
10.1146/annurev.micro.62.081307.163009
10.1128/CMR.14.4.778-809.2001
10.1016/j.semcdb.2004.11.011
10.1128/JVI.78.8.4323-4329.2004
10.1016/S1074-5521(98)90615-9
10.1016/j.biocel.2005.02.018
10.1128/jvi.70.8.5329-5335.1996
10.1371/journal.pone.0002032
10.1016/j.virusres.2009.12.013
10.1128/JVI.74.9.3975-3983.2000
10.1038/nature07013
10.1128/JVI.01238-07
10.1128/JVI.02575-06
ContentType Journal Article
Copyright 2011 © 2011 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.
2011 by The American Society for Biochemistry and Molecular Biology, Inc.
Copyright_xml – notice: 2011 © 2011 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.
– notice: 2011 by The American Society for Biochemistry and Molecular Biology, Inc.
DBID 6I.
AAFTH
FBQ
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7U9
H94
5PM
DOI 10.1074/jbc.M110.149369
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
AGRIS
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AIDS and Cancer Research Abstracts
Virology and AIDS Abstracts
DatabaseTitleList
AIDS and Cancer Research Abstracts

MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: FBQ
  name: AGRIS
  url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
DocumentTitleAlternate Caspase-3 Activation during CCHFV Infection
EISSN 1083-351X
EndPage 3234
ExternalDocumentID PMC3030327
21123175
10_1074_jbc_M110_149369
US201301935510
S0021925820540271
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-DZ
-ET
-~X
0SF
18M
29J
2WC
34G
39C
4.4
53G
5BI
5GY
5RE
5VS
6I.
79B
85S
AAEDW
AAFTH
AAFWJ
AARDX
AAXUO
ABDNZ
ABOCM
ABPPZ
ABRJW
ACGFO
ACNCT
ADBBV
ADIYS
ADNWM
AENEX
AEXQZ
AFOSN
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AOIJS
BAWUL
BTFSW
C1A
CJ0
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
FDB
FRP
GROUPED_DOAJ
GX1
HH5
HYE
IH2
KQ8
L7B
N9A
OK1
P-O
P0W
P2P
R.V
RHF
RHI
RNS
ROL
RPM
SJN
TBC
TN5
TR2
UHB
UKR
UPT
VQA
W8F
WH7
WOQ
XFK
XSW
YQT
YSK
YWH
YZZ
ZA5
~02
~KM
.55
.GJ
186
3O-
41~
6TJ
AAYJJ
AAYOK
ABFSI
ABPTK
ABTAH
ACSFO
ACYGS
AEQTP
AFDAS
AFFNX
AFMIJ
AI.
E.L
F20
FA8
FBQ
J5H
MVM
NHB
OHT
QZG
UQL
VH1
WHG
X7M
XJT
Y6R
YYP
ZE2
ZGI
ZY4
.7T
0R~
AALRI
AAYWO
AAYXX
ACVFH
ADCNI
ADVLN
ADXHL
AEUPX
AFPUW
AIGII
AITUG
AKBMS
AKRWK
AKYEP
CITATION
H13
CGR
CUY
CVF
ECM
EIF
NPM
Z5M
7X8
7U9
H94
5PM
ID FETCH-LOGICAL-c602t-e9842f933a0a38a2673add8d60e9086538381d03f8c469f8feee296044466b5f3
ISSN 0021-9258
1083-351X
IngestDate Thu Aug 21 18:35:07 EDT 2025
Thu Jul 10 18:29:35 EDT 2025
Fri Jul 11 06:55:03 EDT 2025
Wed Feb 19 02:29:58 EST 2025
Thu Apr 24 22:58:20 EDT 2025
Tue Jul 01 01:53:51 EDT 2025
Wed Dec 27 19:17:23 EST 2023
Fri Feb 23 02:46:43 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Viral Replication
Negative-strand RNA Viruses
CCHFV
Nucleocapsid Protein
Caspase
Crimean-Congo Hemorrhagic Fever Virus
Apoptosis
Protein Assembly
Language English
License This is an open access article under the CC BY license.
http://creativecommons.org/licenses/by/4.0
https://www.elsevier.com/tdm/userlicense/1.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c602t-e9842f933a0a38a2673add8d60e9086538381d03f8c469f8feee296044466b5f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
OpenAccessLink https://dx.doi.org/10.1074/jbc.M110.149369
PMID 21123175
PQID 848688131
PQPubID 23479
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3030327
proquest_miscellaneous_904466351
proquest_miscellaneous_848688131
pubmed_primary_21123175
crossref_citationtrail_10_1074_jbc_M110_149369
crossref_primary_10_1074_jbc_M110_149369
fao_agris_US201301935510
elsevier_sciencedirect_doi_10_1074_jbc_M110_149369
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2011-02-04
PublicationDateYYYYMMDD 2011-02-04
PublicationDate_xml – month: 02
  year: 2011
  text: 2011-02-04
  day: 04
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: 9650 Rockville Pike, Bethesda, MD 20814, U.S.A
PublicationTitle The Journal of biological chemistry
PublicationTitleAlternate J Biol Chem
PublicationYear 2011
Publisher Elsevier Inc
American Society for Biochemistry and Molecular Biology
Publisher_xml – name: Elsevier Inc
– name: American Society for Biochemistry and Molecular Biology
References Samuel (bib30) 2001; 14
Kohl, Clayton, Weber, Bridgen, Randall, Elliott (bib34) 2003; 77
Ergönül (bib19) 2006; 6
Schnittler, Feldmann (bib14) 2003; 89
Liljeström, Garoff (bib17) 1991; 9
Barry, Fragkoudis, Ferguson, Lulla, Merits, Kohl, Fazakerley (bib18) 2010; 84
Bray, Geisbert (bib20) 2005; 37
Kang, Park, Lee, Ahn (bib11) 1999; 264
García, Gil, Ventoso, Guerra, Domingo, Rivas, Esteban (bib31) 2006; 70
Clemens (bib33) 2005; 16
Bray, Pilch (bib21) 2006; 4
Majerciak, Kruhlak, Dagur, McCoy, Zheng (bib29) 2010; 285
Lei, Yeh, Liu, Lin, Chen, Liu (bib24) 2001; 8
Thornberry, Lazebnik (bib3) 1998; 281
Zhirnov, Konakova, Garten, Klenk (bib27) 1999; 73
Thornberry (bib2) 1998; 5
Andersson, Karlberg, Mousavi-Jazi, Martínez-Sobrido, Weber, Mirazimi (bib32) 2008; 80
Tarodi, Subramanian, Chinnadurai (bib4) 1994; 201
Won, Ikegami, Peters, Makino (bib8) 2007; 81
Jänicke (bib28) 2009; 117
Habjan, Andersson, Klingström, Schümann, Martin, Zimmermann, Wagner, Pichlmair, Schneider, Mühlberger, Mirazimi, Weber (bib35) 2008; 3
Ontiveros, Li, Jonsson (bib13) 2010; 401
Andersson, Bladh, Mousavi-Jazi, Magnusson, Lundkvist, Haller, Mirazimi (bib16) 2004; 78
Pekosz, Phillips, Pleasure, Merry, Gonzalez-Scarano (bib7) 1996; 70
Eléouët, Slee, Saurini, Castagné, Poncet, Garrido, Solary, Martin (bib26) 2000; 74
Gadaleta, Vacotto, Coulombié (bib5) 2002; 86
Hardestam, Klingström, Mattsson, Lundkvist (bib12) 2005; 76
Akhmatova, Yusupova, Khaiboullina, Sibiryak (bib10) 2003; 8
Chen, Lin, Huang, Wu, Cheng, Lei, Lee, Chiou, Wong, Hsieh (bib22) 2008; 453
Zimmermann, Bonzon, Green (bib1) 2001; 92
Acrani, Gomes, Proença-Módena, da Silva, Carminati, Silva, Santos, Arruda (bib9) 2010; 149
Andersson, Simon, Lundkvist, Nilsson, Holmström, Elgh, Mirazimi (bib15) 2004; 72
Elliott (bib6) 1990; 71
Best (bib25) 2008; 62
Chen, Hofman, Kung, Lin, Wu-Hsieh (bib23) 2007; 81
Zhirnov (10.1074/jbc.M110.149369_bib27) 1999; 73
Lei (10.1074/jbc.M110.149369_bib24) 2001; 8
Won (10.1074/jbc.M110.149369_bib8) 2007; 81
Samuel (10.1074/jbc.M110.149369_bib30) 2001; 14
Chen (10.1074/jbc.M110.149369_bib22) 2008; 453
Gadaleta (10.1074/jbc.M110.149369_bib5) 2002; 86
Andersson (10.1074/jbc.M110.149369_bib16) 2004; 78
Bray (10.1074/jbc.M110.149369_bib21) 2006; 4
Pekosz (10.1074/jbc.M110.149369_bib7) 1996; 70
Tarodi (10.1074/jbc.M110.149369_bib4) 1994; 201
Ergönül (10.1074/jbc.M110.149369_bib19) 2006; 6
Akhmatova (10.1074/jbc.M110.149369_bib10) 2003; 8
Hardestam (10.1074/jbc.M110.149369_bib12) 2005; 76
Thornberry (10.1074/jbc.M110.149369_bib3) 1998; 281
Eléouët (10.1074/jbc.M110.149369_bib26) 2000; 74
Elliott (10.1074/jbc.M110.149369_bib6) 1990; 71
Barry (10.1074/jbc.M110.149369_bib18) 2010; 84
Best (10.1074/jbc.M110.149369_bib25) 2008; 62
Bray (10.1074/jbc.M110.149369_bib20) 2005; 37
Clemens (10.1074/jbc.M110.149369_bib33) 2005; 16
Kohl (10.1074/jbc.M110.149369_bib34) 2003; 77
Kang (10.1074/jbc.M110.149369_bib11) 1999; 264
Habjan (10.1074/jbc.M110.149369_bib35) 2008; 3
Zimmermann (10.1074/jbc.M110.149369_bib1) 2001; 92
García (10.1074/jbc.M110.149369_bib31) 2006; 70
Liljeström (10.1074/jbc.M110.149369_bib17) 1991; 9
Andersson (10.1074/jbc.M110.149369_bib15) 2004; 72
Chen (10.1074/jbc.M110.149369_bib23) 2007; 81
Ontiveros (10.1074/jbc.M110.149369_bib13) 2010; 401
Acrani (10.1074/jbc.M110.149369_bib9) 2010; 149
Thornberry (10.1074/jbc.M110.149369_bib2) 1998; 5
Majerciak (10.1074/jbc.M110.149369_bib29) 2010; 285
Schnittler (10.1074/jbc.M110.149369_bib14) 2003; 89
Jänicke (10.1074/jbc.M110.149369_bib28) 2009; 117
Andersson (10.1074/jbc.M110.149369_bib32) 2008; 80
References_xml – volume: 117
  start-page: 219
  year: 2009
  end-page: 221
  ident: bib28
  publication-title: Breast Cancer Res. Treat.
– volume: 73
  start-page: 10158
  year: 1999
  end-page: 10163
  ident: bib27
  publication-title: J. Virol.
– volume: 80
  start-page: 1397
  year: 2008
  end-page: 1404
  ident: bib32
  publication-title: J. Med. Virol.
– volume: 401
  start-page: 165
  year: 2010
  end-page: 178
  ident: bib13
  publication-title: Virology
– volume: 37
  start-page: 1560
  year: 2005
  end-page: 1566
  ident: bib20
  publication-title: Int. J. Biochem. Cell Biol.
– volume: 4
  start-page: 917
  year: 2006
  end-page: 921
  ident: bib21
  publication-title: Expert Rev. Anti Infect. Ther.
– volume: 16
  start-page: 13
  year: 2005
  end-page: 20
  ident: bib33
  publication-title: Semin. Cell Dev. Biol.
– volume: 92
  start-page: 57
  year: 2001
  end-page: 70
  ident: bib1
  publication-title: Pharmacol. Ther.
– volume: 78
  start-page: 4323
  year: 2004
  end-page: 4329
  ident: bib16
  publication-title: J. Virol.
– volume: 5
  start-page: R97
  year: 1998
  end-page: R103
  ident: bib2
  publication-title: Chem. Biol.
– volume: 14
  start-page: 778
  year: 2001
  end-page: 809
  ident: bib30
  publication-title: Clin. Microbiol. Rev.
– volume: 76
  start-page: 234
  year: 2005
  end-page: 240
  ident: bib12
  publication-title: J. Med. Virol.
– volume: 3
  start-page: e2032
  year: 2008
  ident: bib35
  publication-title: PLoS ONE
– volume: 72
  start-page: 83
  year: 2004
  end-page: 93
  ident: bib15
  publication-title: J. Med. Virol.
– volume: 62
  start-page: 171
  year: 2008
  end-page: 192
  ident: bib25
  publication-title: Annu. Rev. Microbiol.
– volume: 77
  start-page: 7999
  year: 2003
  end-page: 8008
  ident: bib34
  publication-title: J. Virol.
– volume: 84
  start-page: 7369
  year: 2010
  end-page: 7377
  ident: bib18
  publication-title: J. Virol.
– volume: 453
  start-page: 672
  year: 2008
  end-page: 676
  ident: bib22
  publication-title: Nature
– volume: 70
  start-page: 5329
  year: 1996
  end-page: 5335
  ident: bib7
  publication-title: J. Virol.
– volume: 201
  start-page: 404
  year: 1994
  end-page: 407
  ident: bib4
  publication-title: Virology
– volume: 8
  start-page: 37
  year: 2003
  end-page: 46
  ident: bib10
  publication-title: Russ. J. Immunol.
– volume: 74
  start-page: 3975
  year: 2000
  end-page: 3983
  ident: bib26
  publication-title: J. Virol.
– volume: 6
  start-page: 203
  year: 2006
  end-page: 214
  ident: bib19
  publication-title: Lancet Infect. Dis.
– volume: 8
  start-page: 377
  year: 2001
  end-page: 388
  ident: bib24
  publication-title: J. Biomed. Sci.
– volume: 71
  start-page: 501
  year: 1990
  end-page: 522
  ident: bib6
  publication-title: J. Gen. Virol.
– volume: 281
  start-page: 1312
  year: 1998
  end-page: 1316
  ident: bib3
  publication-title: Science
– volume: 264
  start-page: 99
  year: 1999
  end-page: 105
  ident: bib11
  publication-title: Virology
– volume: 81
  start-page: 5518
  year: 2007
  end-page: 5526
  ident: bib23
  publication-title: J. Virol.
– volume: 81
  start-page: 13335
  year: 2007
  end-page: 13345
  ident: bib8
  publication-title: J. Virol.
– volume: 9
  start-page: 1356
  year: 1991
  end-page: 1361
  ident: bib17
  publication-title: Biotechnology
– volume: 285
  start-page: 11297
  year: 2010
  end-page: 11307
  ident: bib29
  publication-title: J. Biol. Chem.
– volume: 86
  start-page: 87
  year: 2002
  end-page: 92
  ident: bib5
  publication-title: Virus Res.
– volume: 89
  start-page: 967
  year: 2003
  end-page: 972
  ident: bib14
  publication-title: Thromb. Haemost.
– volume: 149
  start-page: 56
  year: 2010
  end-page: 63
  ident: bib9
  publication-title: Virus Res.
– volume: 70
  start-page: 1032
  year: 2006
  end-page: 1060
  ident: bib31
  publication-title: Microbiol. Mol. Biol. Rev.
– volume: 92
  start-page: 57
  year: 2001
  ident: 10.1074/jbc.M110.149369_bib1
  publication-title: Pharmacol. Ther.
  doi: 10.1016/S0163-7258(01)00159-0
– volume: 8
  start-page: 377
  year: 2001
  ident: 10.1074/jbc.M110.149369_bib24
  publication-title: J. Biomed. Sci.
  doi: 10.1007/BF02255946
– volume: 285
  start-page: 11297
  year: 2010
  ident: 10.1074/jbc.M110.149369_bib29
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M109.068221
– volume: 401
  start-page: 165
  year: 2010
  ident: 10.1074/jbc.M110.149369_bib13
  publication-title: Virology
  doi: 10.1016/j.virol.2010.02.018
– volume: 89
  start-page: 967
  year: 2003
  ident: 10.1074/jbc.M110.149369_bib14
  publication-title: Thromb. Haemost.
  doi: 10.1055/s-0037-1613397
– volume: 9
  start-page: 1356
  year: 1991
  ident: 10.1074/jbc.M110.149369_bib17
  publication-title: Biotechnology
  doi: 10.1038/nbt1291-1356
– volume: 117
  start-page: 219
  year: 2009
  ident: 10.1074/jbc.M110.149369_bib28
  publication-title: Breast Cancer Res. Treat.
  doi: 10.1007/s10549-008-0217-9
– volume: 4
  start-page: 917
  year: 2006
  ident: 10.1074/jbc.M110.149369_bib21
  publication-title: Expert Rev. Anti Infect. Ther.
  doi: 10.1586/14787210.4.6.917
– volume: 84
  start-page: 7369
  year: 2010
  ident: 10.1074/jbc.M110.149369_bib18
  publication-title: J. Virol.
  doi: 10.1128/JVI.02310-09
– volume: 8
  start-page: 37
  year: 2003
  ident: 10.1074/jbc.M110.149369_bib10
  publication-title: Russ. J. Immunol.
– volume: 201
  start-page: 404
  year: 1994
  ident: 10.1074/jbc.M110.149369_bib4
  publication-title: Virology
  doi: 10.1006/viro.1994.1309
– volume: 70
  start-page: 1032
  year: 2006
  ident: 10.1074/jbc.M110.149369_bib31
  publication-title: Microbiol. Mol. Biol. Rev.
  doi: 10.1128/MMBR.00027-06
– volume: 76
  start-page: 234
  year: 2005
  ident: 10.1074/jbc.M110.149369_bib12
  publication-title: J. Med. Virol.
  doi: 10.1002/jmv.20347
– volume: 72
  start-page: 83
  year: 2004
  ident: 10.1074/jbc.M110.149369_bib15
  publication-title: J. Med. Virol.
  doi: 10.1002/jmv.10560
– volume: 80
  start-page: 1397
  year: 2008
  ident: 10.1074/jbc.M110.149369_bib32
  publication-title: J. Med. Virol.
  doi: 10.1002/jmv.21222
– volume: 6
  start-page: 203
  year: 2006
  ident: 10.1074/jbc.M110.149369_bib19
  publication-title: Lancet Infect. Dis.
  doi: 10.1016/S1473-3099(06)70435-2
– volume: 281
  start-page: 1312
  year: 1998
  ident: 10.1074/jbc.M110.149369_bib3
  publication-title: Science
  doi: 10.1126/science.281.5381.1312
– volume: 71
  start-page: 501
  year: 1990
  ident: 10.1074/jbc.M110.149369_bib6
  publication-title: J. Gen. Virol.
  doi: 10.1099/0022-1317-71-3-501
– volume: 86
  start-page: 87
  year: 2002
  ident: 10.1074/jbc.M110.149369_bib5
  publication-title: Virus Res.
  doi: 10.1016/S0168-1702(02)00049-7
– volume: 264
  start-page: 99
  year: 1999
  ident: 10.1074/jbc.M110.149369_bib11
  publication-title: Virology
  doi: 10.1006/viro.1999.9896
– volume: 73
  start-page: 10158
  year: 1999
  ident: 10.1074/jbc.M110.149369_bib27
  publication-title: J. Virol.
  doi: 10.1128/JVI.73.12.10158-10163.1999
– volume: 77
  start-page: 7999
  year: 2003
  ident: 10.1074/jbc.M110.149369_bib34
  publication-title: J. Virol.
  doi: 10.1128/JVI.77.14.7999-8008.2003
– volume: 62
  start-page: 171
  year: 2008
  ident: 10.1074/jbc.M110.149369_bib25
  publication-title: Annu. Rev. Microbiol.
  doi: 10.1146/annurev.micro.62.081307.163009
– volume: 14
  start-page: 778
  year: 2001
  ident: 10.1074/jbc.M110.149369_bib30
  publication-title: Clin. Microbiol. Rev.
  doi: 10.1128/CMR.14.4.778-809.2001
– volume: 16
  start-page: 13
  year: 2005
  ident: 10.1074/jbc.M110.149369_bib33
  publication-title: Semin. Cell Dev. Biol.
  doi: 10.1016/j.semcdb.2004.11.011
– volume: 78
  start-page: 4323
  year: 2004
  ident: 10.1074/jbc.M110.149369_bib16
  publication-title: J. Virol.
  doi: 10.1128/JVI.78.8.4323-4329.2004
– volume: 5
  start-page: R97
  year: 1998
  ident: 10.1074/jbc.M110.149369_bib2
  publication-title: Chem. Biol.
  doi: 10.1016/S1074-5521(98)90615-9
– volume: 37
  start-page: 1560
  year: 2005
  ident: 10.1074/jbc.M110.149369_bib20
  publication-title: Int. J. Biochem. Cell Biol.
  doi: 10.1016/j.biocel.2005.02.018
– volume: 70
  start-page: 5329
  year: 1996
  ident: 10.1074/jbc.M110.149369_bib7
  publication-title: J. Virol.
  doi: 10.1128/jvi.70.8.5329-5335.1996
– volume: 3
  start-page: e2032
  year: 2008
  ident: 10.1074/jbc.M110.149369_bib35
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0002032
– volume: 149
  start-page: 56
  year: 2010
  ident: 10.1074/jbc.M110.149369_bib9
  publication-title: Virus Res.
  doi: 10.1016/j.virusres.2009.12.013
– volume: 74
  start-page: 3975
  year: 2000
  ident: 10.1074/jbc.M110.149369_bib26
  publication-title: J. Virol.
  doi: 10.1128/JVI.74.9.3975-3983.2000
– volume: 453
  start-page: 672
  year: 2008
  ident: 10.1074/jbc.M110.149369_bib22
  publication-title: Nature
  doi: 10.1038/nature07013
– volume: 81
  start-page: 13335
  year: 2007
  ident: 10.1074/jbc.M110.149369_bib8
  publication-title: J. Virol.
  doi: 10.1128/JVI.01238-07
– volume: 81
  start-page: 5518
  year: 2007
  ident: 10.1074/jbc.M110.149369_bib23
  publication-title: J. Virol.
  doi: 10.1128/JVI.02575-06
SSID ssj0000491
Score 2.265215
Snippet Regulation of apoptosis during infection has been observed for several viral pathogens. Programmed cell death and regulation of apoptosis in response to a...
SourceID pubmedcentral
proquest
pubmed
crossref
fao
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 3227
SubjectTerms Animals
Apoptosis
Caspase
Caspase 3 - metabolism
Caspase inhibitors
Caspase-3
CCHFV
Cell Line
Cell Line, Tumor
Cell survival
Chlorocebus aethiops
Conserved sequence
Crimean-Congo Hemorrhagic Fever Virus
Data processing
Defense mechanisms
Enzyme Activation
Hemorrhagic fever
Hemorrhagic Fever Virus, Crimean-Congo - pathogenicity
Hemorrhagic Fever, Crimean - immunology
Hemorrhagic Fever, Crimean - pathology
Host-Pathogen Interactions - immunology
Humans
Hydrolysis
Infection
Microbiology
Negative-strand RNA Viruses
Nucleocapsid Protein
Nucleocapsid Proteins - metabolism
Nucleocapsids
Pathogens
Peptide Hydrolases
Progeny
Protein Assembly
Proteolysis
Replication
RNA
Site-directed mutagenesis
Vero Cells
Viral Replication
Title Induction of Caspase Activation and Cleavage of the Viral Nucleocapsid Protein in Different Cell Types during Crimean-Congo Hemorrhagic Fever Virus Infection
URI https://dx.doi.org/10.1074/jbc.M110.149369
https://www.ncbi.nlm.nih.gov/pubmed/21123175
https://www.proquest.com/docview/848688131
https://www.proquest.com/docview/904466351
https://pubmed.ncbi.nlm.nih.gov/PMC3030327
Volume 286
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtNAEF2l5QFeKmiBhpv2ASGkysHedXx5rEKjqrRFiASFJ2vtrFNLiV0lDhL9Az6Cf2Vm12s7pREXKbJiZ-04meO57M6cIeQ14xKsmBNaoPg8yw36qRVLAcEKF4nD09CTHtY7X1x6p2P3bNKfdDo_WllL6zLuJTd31pX8j1ThGMgVq2T_QbL1ReEAvAf5whYkDNu_kjH23UiMyzcQoByQZiQxHcvUwsBgLsU3MauTAb5kWJJ_iTTGYMau4aaxWAB7XuLUx_uqX0p5NMBJPYxSV6aUETuASZFbgyKfFWCvFsVyeSVAcx4NJfx1eOX1ChSOzu7K225vU4CmXF_N_KS5SUzDuVrzi-Xc5Jwpm9jMLSgF-VVK66woaqDAz7nJFpku1snakxg4K8ss3Xa4LipwrJBpFnejmFlFkp21176VmgUt5LdMNmd6QvQ3cwD-EZqDOOktHNx3sX1hY_nMav_lx2g4Pj-PRieT0Q65xyDiwGYYHz41xPMQSOnmi9V9GpYo33136_LbHJydVBR3hTG3s3Fb7s3oIdmrhEOPNcgekY7M98nBcS7KYvGdvqEqU1gtweyT-wMjtAPys8YgLVJaYZA2GKSAQWowiEMAg1RhkLYxSCsMUnjVGKSIQaowSDUG6QYGaQuDVGGQKgzSGoOPyXh4MhqcWlXLDyvxbFZaMgxcloacC1vwQDDP52CAg6lnyxCCb7DO4GFObZ4GieuFaZBKKRnyC2FaQtxP-ROymxe5PCQ08ZmTxHDmNGAuZ3bMwfXymevJQPAkdrukZ-QUJRUfPrZlmUcqL8N3IxBsdOHgnhJsl7ytT7jWVDDbhzIj-KjyZLWHGgEyt590CBCJxAysezT-zDCnwMH2B47dJdTgJgL54pqeyGWxXkWBG3hB4HBn-5BQ5WzwPgx5qpFW3z6DaAsDiC7xNzBYD0Dy-c1P8uxKkdCD62tz5j_789c-Jw-aR_4F2S2Xa_kSPPkyfqWesV8Akfd-
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Induction+of+Caspase+Activation+and+Cleavage+of+the+Viral+Nucleocapsid+Protein+in+Different+Cell+Types+during+Crimean-Congo+Hemorrhagic+Fever+Virus+Infection&rft.jtitle=The+Journal+of+biological+chemistry&rft.au=Karlberg%2C+Helen&rft.au=Tan%2C+Yee-Joo&rft.au=Mirazimi%2C+Ali&rft.date=2011-02-04&rft.issn=0021-9258&rft.volume=286&rft.issue=5&rft.spage=3227&rft.epage=3234&rft_id=info:doi/10.1074%2Fjbc.m110.149369&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9258&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9258&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9258&client=summon